Clinical trial

Study of ARO-MUC5AC in Healthy Subjects and Patients With Muco-Obstructive Lung Disease

NCT05292950

StatusTERMINATED

Study typeINTERVENTIONAL

Start date2022-06-27

PhasePHASE1 / PHASE2

Study timeline

Study start (actual)2022-06-27Date precision: day

Registry last updated2026-09-14

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Asthmaunresolved

Chronic Obstructive Pulmonary Diseaseunresolved

Interventions

ARO-MUC5ACDRUG

PlaceboDRUG

Sponsors & collaborators

Arrowhead Pharmaceuticalslead sponsor

Mapped research locations

SeoulSouth Korea1 BarcelonaSpain1 KrakowPoland1 BialystokPoland1 BangkokThailand1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT05292950 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.